Cyclooxygenase-2: A molecular target for chemoprevention of epithelial tumors of skin and colon

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 445-448

  Muller Decker K ^a   Charyalertsak, S ^a   Albert, C ^a   Reinerth, G ^a   Marks, F ^a   Furstenberger G ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; ACETYLSALICYLIC ACID; ANTHRACENE DERIVATIVE; ARACHIDONIC ACID; CARCINOGEN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENDOPEROXIDE; ENZYME; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL ESTER; PIROXICAM; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SULINDAC; THROMBOXANE A2; TRICYCLIC ANTIDEPRESSANT AGENT; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; BIOSYNTHESIS; CANCER REGRESSION; CATALYSIS; CELL GROWTH; CELL TYPE; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLON TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; EPITHELIUM TUMOR; HUMAN; ISOMERISM; KERATINOCYTE; MOLECULE; MOUSE; MUTATION; NONHUMAN; ONCOGENE H RAS; PAPILLOMA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN EPITHELIUM; SKIN TUMOR; TUMOR CELL CULTURE; TUMOR PROMOTION; ANIMAL; ARTICLE; DISEASE MODEL; EPITHELIUM CELL; GENETICS; INTESTINE MUCOSA; PATHOLOGY;

ANIMALIA;

ANIMALS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SKIN NEOPLASMS;

EID: 18744427749     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_69     Document Type: Conference Paper

References (15)

1. 1. W.E. Smalley, and R.N. DuBois, Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv. Pharmacol. 39:1 (1997).
2. C.J. Barnes, and M. Lee, Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli min mouse model with aspirin. Gastroenterol 114:873 (1998).
3. V.R. Chinthalapally, A. Rivenson, B. Simi, E. Zang, G. Kelloff, V. Steele, and B.S. Reddy, Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res 55:1464 (1995).
4. G. Fürstenberger, M. Gross, and F. Marks, Eicosanoids and multistage carcinogenesis in NMRI mouse skin: Role of prostaglandin E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis 10:91 (1989).
5. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 56:710 (1996).
6. K. Müller-Decker, A. Kopp-Schneider, F. Marks, K. Seibert, and G. Fürstenberger, Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: suppression of skin tumor promotion by COX-2 inhibition. Molec. Carc. 23:36 (1998).
7. S. Fischer, H.H. Lo, G.B. Gordon, K. Seibert, G. Kelloff, R.A. Lubet, and C.J. Conti, Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Molec. Carc. 25:231 (1999).
8. M. Oshima, J.E. Dinchuk, S.L. Kargman, H. Oshima, B. Hancock, E. Kwong, J.M. Trzaskos, J.F. Evans, and M.M. Taketo, Suppression of intestinal poliposis in Apc 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803 (1996).
9. J.R. Vane, Y.S. Bakhle, and R.M. Botting, Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. 38:97 (1998).
10. S. Chariyalertsak, V. Sirikulchayanonta, D. Mayer, A. Kopp-Schneider, G. Fürstenberger, F. Marks, and K. Müller-Decker, Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. Gut, accepted 2000.
11. K. Müller-Decker, C. Albert, T. Lukanov, G. Winde, F. Marks, and G. Fürstenberger. Cellular localization of cyclo-oxygenase isozymes in Crohn's disease and colorectal cancer. Int. J. Colorectal Dis. 14:212 (1999).
12. K. Müller-Decker, K. Scholz, F. Marks, and G. Fürstenberger, Differential expression of prostaglandin H synthase isoenzymes during multistage carcinogenesis in mouse epidermis. Molec. Carc. 12:31 (1995).
13. K. Müller-Decker, G. Reinerth, P. Krieg, R. Zimmermann, H. Heise, C. Bayerl, F. Marks, and G. Fürstenberger, Prostaglandin H synthase isoenzyme expression in normal and neoplastic human skin. Int. J. Cancer 82:648 (1999).
14. S.Y. Buckman, A. Gresham, P. Hale, G. Hruza, J. Anast, J. Masferrer, and A.P. Pentland, COX-2 expression is induced by UVB exposure in human skin: implications for development of cancer. Carcinogenesis 19:723 (1998).
15. T. Kawamori, C.V. Rao, K. Seibert, B.S. Reddy, Chemopreventive activity of Celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58:409 (1998).